EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Volume 15 Issue 4

FDA Focus on the Safety of Gene Therapy Products

Within the past 6 years, the US Food and Drug Administration (FDA) has approved a growing number of cellular and gene therapy products to treat a variety of conditio...
Continue Reading →
Volume 15 Issue 2

Exploring the Limb Girdle Muscular Dystrophy Clinical Trial Landscape

With the recent advent of adeno-associated, virus-based gene therapy treatments, limb-girdle muscular dystrophy (LGMD) is currently attracting the attention of the b...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Pharmap: Wed 13 November 2024, 10:36
Biosynth: Wed 13 November 2024, 10:18